OncoMed Signs Second Cancer Stem Cell Partner; This Time It's Bayer
This article was originally published in The Pink Sheet Daily
Executive Summary
Deal with Bayer to discover and develop Wnt pathway therapies follows 2007 deal with GSK focused on Notch pathway.